Special Report: Mounjaro Sales Hit ₹100 Crore as Weight Loss Drugs Define 2025 Health Trends

In this detailed health wrap, the focus is on the transformative trends that defined 2025 in India. An unidentified speaker breaks down the massive disruption caused by GLP-1 weight loss therapies, revealing that Mounjaro clocked ₹100 crore in sales in October alone, overtaking long-established antibiotics. The report highlights how obesity is finally being accepted as a chronic condition rather than a lifestyle failure. The discussion also moves to the mainstreaming of the 'inflammation' conversation, with Indians shifting towards plant-based, anti-inflammatory diets. Finally, the programme explores 'Fiber Maxing' and the critical role of gut health in immunity and mental well-being, marking a shift from calorie counting to metabolic resilience.